|Publication number||USRE30101 E|
|Application number||US 05/589,360|
|Publication date||Sep 25, 1979|
|Filing date||Jun 23, 1975|
|Priority date||Aug 19, 1964|
|Publication number||05589360, 589360, US RE30101 E, US RE30101E, US-E-RE30101, USRE30101 E, USRE30101E|
|Inventors||William G. Kubicek, Edwin Kinnen, Robert P. Patterson, David A. Witsoe|
|Original Assignee||Regents Of The University Of Minnesota|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (8), Non-Patent Citations (3), Referenced by (118), Classifications (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to plethysmographs and particularly to an impedance plethysmograph and process of using the same. The invention is particularly useful in determining cardiac output.
In accordance with the present invention, a current flux is distributed in the mammalian thorax by the placement of electrodes at the neck and lower thorax. According to one form of the invention the electrodes have the form of bands positioned to encircle the neck and thorax. To these electrodes is applied a fluctuating excitation current. The impedance of the thorax is then measured with either the same electrodes or with different electrodes to obtain information concerning cardiac activity and particularly cardiac output.
In evaluating the invention, measurements have been made which indicate that the major portion of excitation current flux passed through the lung tissues, rather than through the lower resistivity volume of the major thoracic arteries, veins and the heart. Accordingly, it is possible to measure the blood volume changes of the lungs and derive cardiac output from the impedance changes.
The evaluations were based upon measurements of current densities around different regions on the circumference of the electrodes, equipotential surfaces constructed from both surface and interior potential measurements, externally observed directed flux impedance waveforms and tests conducted with a model representing the thorax. The impedance plethysmographic waveforms obtained between the electrodes appeared to monitor the pulmonary flow as reflected by impedance changes in the pulmonary vascular bed.
The invention is based on the measurement of electrical impedance changes in the thorax during application of a fluctuating current (such as a 100 kc. current having RMS value of 5.0 ma.) between electrodes placed on the surface of the thorax. This procedure provides the advantage of minimum subject preparation and constraint.
A variety of electrodes have been investigated for potential use. Results obtained with four braided band electrodes, two positioned around the neck and two placed around the subject's midsection have been the most acceptable. The experimentally determined values of cardiac output obtained from these impedance measurements have been found to be significantly correlated to simultaneously performed studies using the Fick and dye dilution procedures as reported, for example, in Circulatory Physiology: Cardiac Output and Its Regulation, Arthur C. Greyton, W. B. Saunders Co., 1963, pages 21-71. The system according to the present invention has also been shown to be relatively insensitive to body type and lung air volume.
To verify the determination of cardiac output from impedance measurements, an understanding of the physiological phenomena responsible for the measured variations must be obtained. In particular the excitation current flux paths in the thorax between the excitation electrodes must be established.
It has been found that the only tenable theoretical flux distribution path is that in which the majority of .[.he.]. .Iadd.the .Iaddend.current flux passes from the band electrodes into the lung volume and tends to avoid the heart blood volume regions. Consequently, this current flux distribution implies that the measured impedance is an indication of the total movement of blood in the pulmonary vascular bed.
The impedance waveforms obtained with two band electrodes, one positioned at the neck and the other about 2 cm. below the xiphisternal joint, appeared to reflect the pulmonary blood pulsations in the lungs rather than the direct ventricular volume change. The equipotential surfaces sketched from thorax potential measurements indicated a flow of current from the blood volume regions. The largest density of the current leaving a band electrode positioned at the midsection of the thorax was found at the base of the lungs on the posterior thorax.
Each of these results would indicate that in an electrode configuration including one band electrode about the neck and another about the thorax as set forth above, the majority of the currrent flux passed through the lungs, such that the major observed impedance characteristics were controlled by the pulsating pulmonary volume changes. Furthermore, the relatively accurate cardiac output determinations made by these impedance measurements were apparently based on an indirect indication of right ventricular stroke volume as reflected by the pulmonary vascular bed.
Among the objects of the invention is the provision of a method and apparatus for sensing and recording cardiac output.
Another object of the invention is the provision of a plethysmographic system for obtaining a record of cardiac output wherein a minimum of subject restraint is required and wherein no surgical procedure is necessary.
Another object of the invention is the provision of an improved plethysmographic process and apparatus suitable for use in routine physical testing to obtain a record from which cardiac output can be derived.
Another object of the invention is the provision of an improved plethysmographic process and apparatus including a reliable means for eliminating errors caused by skin impedance at the stimulating electrodes.
Yet another object of the invention is the provision of an improved process and apparatus for measuring and recording cardiac output wherein a single manual adjustment is required to set the electrically sensing and recording devices of the invention in condition for making a recording.
Yet another object of the invention is the provision of an improved means for sensing and recording impedance changes in an organ wherein the reactive component of the impedance of the organ will not prevent making reliable impedance readings.
Yet another object of the invention is the provision of an improved means for measuring cardiac output wherein a first set of electrodes are placed respectively at the upper and lower ends of the thorax to provide electrical stimulation and a second pair of measuring electrodes are attached to the thorax intermediate the excitation electrodes.
A still further object of the invention is the provision of an improved plethysmographic apparatus and process for measuring cardiac output including a means for generating a constant fluctuating current to excite the tissue, a means for applying the current thus generated to the thorax of an animal, a sensing means connected to the thorax for receiving a signal from which the impedance between two spaced apart points can be measured, a balancing means connected to the current generating means for matching the current produced by the current generating means with the signal thus sensed and a means for rectifying both the excitation signal and the sensed signal and for comparing the signal thus sensed with the excitation signal.
Other objects of the invention will become apparent as the description proceeds.
To the accomplishment of the foregoing and related ends, this invention then comprises the features hereinafter fully described and particularly pointed out in the claims, the following description setting forth in detail certain illustrative embodiments of the invention, these being indicative, however, of but a few of the various ways in which the principles of the invention may be employed.
The invention is illustrated by the accompanying drawings in which the same numerals refer to corresponding parts and in which:
FIG. 1 is a partial front elevational view of a human subject showing the position of the excitation and measuring electrodes when placed in position for use;
FIG. 2 is a diagram representing a portion of a strip chart record prepared in accordance with the system of the present invention and including a record of audible heart sounds at the top thereof and at the bottom a record of the impedance changes in the thorax as measured by the use of the system of the invention;
FIG. 3 is a schematic block diagram illustrating the means used for connecting the current excitation and recording electrodes in accordance with the system of the invention;
FIG. 4 is a schematic circuit diagram of the current excitation oscillator and recording means of the system of the invention;
FIG. 5 is a partial diagrammatic view of a mammalian body illustrating typical equipotential surfaces as determined in the evaluation of the system of the invention; and
FIG. 6 is a diagram illustrating the position and direction of current flux lines between the stimulating electrodes of the system of the invention.
Referring now to the figures of the drawings which illustrate by way of example a preferred form of practicing the invention, there is shown in FIGS. 1 and 3 a pair of current excitational electrodes A and D each desirably formed from a braided copper wire. The electrodes A and D are positioned, respectively, at the upper portion of the neck and around the lower abdomen. Positioned intermediate the electrodes A and D is a pair of measuring electrodes B and C, the electrode B being positioned at the base of the neck and the electrode C approximately 2 cm. below the xiphisternal joint with the skin of the thorax. The electrodes B and C are also desirably constructed of braided copper wire.
As shown in FIG. 3, there is provided a constant current oscillator 10, the construction of which will be described more fully hereinbelow, and including an output lead 12 which is connected to the electrode A and an output lead 14 connected to the electrode D. The oscillator 10 is of the type adapted to produce a constant fluctuating current, such as a 100 kc. alternating current. The oscillator 10 passes the same current applied through the conductors 12 and 14 through a set of conductors 16 and 18 which are connected to the ends of the balancing potentiometer 20.
Connected to the electrode B by means of a conductor 22 is an alternating current amplifier 24 which will be described more fully hereinbelow. A similar amplifier 26 is connected to the slide arm 28 of the potentiometer 20. The outputs of the amplifiers 24 and 26 are fed through conductors 30 and 32, respectively, to rectifying means, such as detectors 34 and 36, to a subtraction or comparing means such as a DC differential amplifier 42. A conductor 44 is connected between the electrode C and the differential amplifier 42. The output signal produced by the differential amplifier 42 is fed through a pair of conductors 46 and 48 to a suitable measuring and recording instrument such as a strip chart recorder 50, as seen in FIG. 4.
The skin impedance is eliminated by introducing into the thorax a current with the two outer electrodes using the constant current source 10 and then measuring a voltage between the inner electrodes that is proportional to the electrical impedance. Since the current is constant, the voltage equals a constant times the impedance. If the electrical input impedance of the instrument that measures the voltage between the inner electrodes is very high compared with the impedance between the inner electrodes, very little current will flow to the electrodes and, therefore, very little skin impedance will be measured.
In FIG. 2 there will be seen a strip of recording paper 51 upon which heart sounds are recorded as a trace 53. Trace 53 includes a plurality of peaks 55 and 57 which indicate, respectively, the opening of the heart valve during systole and the closing of the heart valve at the end of systole. At the lower portion of the graph is recorded a trace 59 representing impedance measurements obtained from the differential amplifier 42. From the peaks 55 and 57 are constructed vertical lines 61 and 63. A third line 65 is constructed by drawing a straight line tangent to the maximum decreasing impedance slope at 67 during systole and extending this line to the first and second heart sounds or, in the alternative, to any other means indicating the beginning and end of systole. Where the extended line 65 intersects the lines 61 and 63, horizontal lines 69 and 71 are constructed. The distance between lines 71 and 69 is measured to find ΔZ. Flow during each stroke of the heart continues between the opening of the heart valve as shown by the peak 55 and the closing of the valve at the end of systole as shown by the peak 57. The flow rate is a function of the rate of change of the impedance as shown by the slope at 67. Thus, by constructing line 65 between the opening and closing of the valves during systole a determination can be made of the theoretical change in impedance (ΔZ) which takes into account all of the blood injected during that stroke into the thorax. The impedance change ΔZ (across the electrodes B and C) can be determined from the distance between lines 69 and 71 by producing a known impedance change and measuring the height of the deflection peak caused by this change in the trace 59.
Referring now to FIG. 4, and particularly to the constant current oscillator 10, it will be seen that current is provided from a 30 volt power supply (not shown) across lines 60 and 62. Connected to line 62 is a line 64 which is coupled to the emitter of a transistor Q1 through a variable resistance R6 in parallel with a fixed resistance R11. Line 62 is also connected through the line 64 to a fixed resistance R4 in parallel with a capacitance C3. Connected to line 60 in series with the resistance R4 and capacitance C3 are two parallel connected resistances R2 and R3. The base of Q1 is connected through a resistance R1 in series with parallel connected capacitances C1 and C2 and a capacitance C5 to the collector of a transistor Q2. The collector of Q1 is connected through a resistance R5 to line 60 and through a capacitance C4 to the base of Q2. Line 64 is also connected to line 60 through series connected resistances R7 and R9.
The emitter of Q2 is connected to line 64 through a resistance R8 while the collector thereof is connected to line 60 through a resistance R10 and to the base of a transistor Q3 through a capacitance C6. The base of Q3 is also connected to line 60 through resistance R12 which the emitter thereof is connected to line 62 through parallel connected resistances R13 and R16 in series with resistance R14. The collector of transistor Q3 is connected directly to line 60 by means of a conductor 65. The output of the transistor Q3 is fed through a line 66 connected between R13 and R16 and R14 and through capacitance C7 to the base of a transistor Q4, said base also being connected to line 60 through a resistance R15. The emitter of Q4 is wired through parallel connected resistances R17 and R18 with the line 62. The collector of Q4 is connected to the series coupled primary coils of transformers T1 and T2, the free terminal of the primary of T2 being connected to line 60.
The secondary of the transformer T2 is connected by means of the conductors 12 and 14 to the electrodes A and D, while the secondary of the transformer T1 is connected by means of the conductors 16 and 18 to the balancing potentiometer 20. In this manner, an oscillating output signal is fed in phase and in equal strength to both the excitation electrodes A and D and to the DC amplier 26 through the potentiometer 20.
The amplifier 24 includes a pair of transistors Q5 and Q7. The base of Q5 is connected to the electrode B through a capacitance C8. The collector of Q5 is connected to the base of Q7 through a capacitance C10. Connected between C10 and Q5 and a power supply line 70 is a resistance R24. Between the base of Q7, C10 and the line 70 is a resistance R28. Line 70 is connected to a suitable source of current, such as a 30 volt power supply, by means of a terminal 72. Line 70 is connected directly to the collector of Q7 through a line 74. The base and emitter of Q5 are connected to ground through resistances R21 and R25 respectively. The emitter of Q7 is connected to ground through a resistance R30 and to the diode 34 through a capacitance C12. One side of diode 34 is connected to ground through a resistance R32 and the other side is connected to ground through a capacitance C14.
The amplifier 26 includes a pair of transistors Q6 and Q8. Power is supplied through a line 80 to the base of Q6 through a resistance R23 and to the collector thereof through a resistance R27. Line 80 is also connected to the base of Q8 through a resistance R29 and directly to the collector through a conductor 82. The emitters of Q6 and Q8 are grounded through resistances R26 and R31, respectively. The base of Q6 is connected to ground through a resistance R22 and to the slide arm of the potentiometer 20. Between the collector of Q6 and the base of Q8 is a capacitance C11. The emitter of Q8 is connected through a capacitance C13 with the diode 36. The diode 36 is also connected to ground through a resistance R33 and the other side thereof is connected to ground through capacitance C15. In this manner, the output of the amplifiers 24 and 26 is rectified by the detectors 34 and 36 and the signals are subtracted by means of the differential amplifier 42. Any difference in the signals is either observed on the meter (not shown) connected to the lines 46 and 48 at the output of the differential amplifier 42 or recorded by means of recorder 50. It should also be seen that through the use of the present invention the capacitance component of the impedance will not interfere with accurate readings since phase differences are eliminated by rectifying the signals before they are compared and the difference recorded.
By way of example, the following circuit constants can be employed. The resistors have a 1/2 watt rating unless otherwise specified.
______________________________________ Q1, 2, 3 T1495.Q4 T1487.Q5, 6 2N930.Q7, 8 2N336.34, 36 1N625.C6 .05 mfd.C7 .5 mfd.C8, 9 100 mfd.C10, 11 220 mfd.R1, 4, 14 2.2KΩ.R2 82KΩ.C1 45-25 mfd.C2 300 mfd.C3 270 mfd.C4, 12, 13 .001 mfd.C5, 14, 15 .01 mfd.R3, 5 10KΩ.R7 47KΩ.R8 1KΩ.R9, 28, 29 330KΩ.R10, 11 6.8KΩ.R12 1MEGΩ.R15 39KΩ.R16, 25, 26, 30, 31 4.7KΩ.R17 100Ω, 1 watt.R18 47Ω, 1 watt.R20, 23 3.9MEGΩ.R21, 22 680KΩ.R24, 27, 32, 33 27KΩ.R6 1MEGΩ trimpot.R13 20KΩ trimpot.20 100Ω trimpot.T1 and 2 5 : 1 turns ratio.______________________________________
In operation, the balancing potentiometer 20 is adjusted until there is an approximate zero steady state voltage at the output of the DC differential amplifier. Since an equal amount of current is passed through the thorax and through the balancing potentiometer 20, the voltage across each of them is proportional to the impedance of each. Therefore, when the plethysmograph is balanced, the resistance of the balancing potentiometer will equal the impedance magnitude between the inner electrodes. Since the balancing signal is obtained from the excitation signal, any variations in the excitation signal are balanced out, thereby eliminating artifacts caused by variations in the excitation signal. The small changing voltage from the DC differential amplifier which is caused by the change of impedance between the two inner electrodes is then fed to a graphic recorder. While the record is made the subject is instructed to hold his breath.
Refer now to FIG. 5 which illustrates the equipotential planes constructed in evaluating the use of the invention. To compile this data, a pair of excitation electrodes 90 and 92 were placed around the neck and lower torso, respectively. A third electrode 94 was used as a movable probe to record potential at any location on the surface of the body or within the body. To this end, the electrode 94 was in some instances swallowed or inserted into other body cavities such as bronchi. A 100 kc. electrical excitation current of about 5 ma. was applied to the electrodes 90 and 92.
The electrodes 90 and 92 were connected in place of electrodes A and D of FIGS. 1, 3 and 4 and the electrode 94 was connected to the conductor 44. The band electrodes 90 and 92 of FIG. 5 were made from tinned copper braid shielding. The braid was stretched to a width of about 1 cm. and coated on the inner side with electrode paste to provide a low impedance skin contact. The electrodes were applied approximately 5 min. before data were taken to allow the skin and paste to reach an equilibrium condition. For the two band electrode placement shown in FIG. 5, and the 100 kc. excitation frequency used throughout this investigation, the thorax presented an average impedance of 37 ohms with a phase angle of 15°.
Several probe configurations were used in conjunction with the impedance plethysmograph to measure potential points on the surface and at various internal points of the thorax of human subjects and dogs. The external thorax surface probe was a 3/4 in. circular brass disc. The probe used for potential measurements in the human esophagus was machined from stainless steel and attached to a nasogastric tube. A probe similar to the human esophagus probe but of larger dimension was used for measuring potentials in the trachea and large bronchi of dogs. To obtain measurements in the lower esophagus, an electrode was constructed with the metal contact from the lung probe mounted at the end of a 1/4 inch rigid Plexiglas tube. A 0.003 inch stainless steel wire inserted in a saline irrigated catheter was used to determine potentials in the aorta, heart, and carotid artery. The esophagus electrode was swallowed by the subject and positioned by X-ray. The other electrodes were inserted orally or surgically into dogs anesthetized with sodium pentobarbitol, and positioned by X-ray and catheter length measurements.
The waveforms obtained while attempting to direct the current flux through particular portions of the thorax by placing electrodes A and D in selected locations showed there was a dominant characteristic of decreasing impedance during systole. The impedance decrease during systole exhibited by the waveform of the two excitation band electrode configuration of FIGS. 1 and 3 suggested that the dominant characteristic being observed is the movement of low resistivity blood into the thoracic regions carrying the majority of the current flux, as described in connection with FIG. 6. The two possible regions in which this can occur are the pulmonary vascular bed, and the heart and arterial system. As the voltage drop between the neck electrode and position 1 was due to a constant current source, the effect of blood pulsations in the arteries above the rib cage appeared to produce minor contributions, if any, to the observed two band waveform.
Although current flux densities cannot be readily determined from equipotential surfaces, the direction of current flow can be established from a knowledge of these surfaces. With the direction of current flow normal to the equipotential surfaces, it is seen from FIG. 5 that the current flux for the two band electrode configuration appeared to be moving out from the center of the thorax volume. It should be noted that the equipotential planes of FIG. 5 suggest movement of flux away from the central regions.
The smallest electrode current density measured with the segmented electrode was found for the segment located nearest the heart apex. If the aorta and superior vena cava carried the majority of the current flux in the upper thorax, the flux would be expected to continue into the lower resistivity blood volume of the heart. The contrary observation indicated that relatively little current flux passed through the heart for the two band electrode configuration of FIG. 5.
In preparing the diagram illustrating the equipotentials, the following potential surfaces were designated: 40 mv., 35 mv., 30 mv., 25 mv., 24 mv., 20 mv., 18 mv., 15 mv. and 10 mv., as can be seen in FIG. 5. These surfaces extend downwardly at their center to a greater extent at the upper part of the thorax than at the lower part of the thorax. The numerical values are proportional to impedance values because the current is constant.
These studies indicate the position of flux lines at 100 as seen in FIG. 6 and pass almost entirely through the lung tissue 102 rather than through the heart, which is indicated diagrammatically at 104. As can also be seen in FIG. 6, the blood leaving the right ventricle 106 through the pulmonary artery 108 passes through the lungs to the left atrium through the pulmonary vein 110. It is thus concluded that the changes in impedance of the lungs are determined by the changes of the voltage between the electrodes B and C as a function of the stroke volume.
Cardiac output is calculated by multiplying the stroke volume, ΔV by the pulse rate. ΔV is calculated as follows: ##EQU1## P=the resistivity of blood L=the distance in centimeters between the stimulating electrodes A and D
Z=the base or static impedance between the electrodes C and B
Δz=measured change in impedance between the electrodes as calculated in the manner described in connection with FIG. 2.
In normal subjects this is the right cardiac output and in patients with congenital heart defects the cardiac output value will include blood flow shunted from the left heart to the pulmonary circulation.
The invention will be best understood by reference to the following examples. In calculating the cardiac output in the Examples 1 through 4, L was 27 centimeters, Z was 31.9 ohms and P was 150 ohms/cm.
TABLE I______________________________________ Example 1 Example 2 Example 3______________________________________ΔZ 85Ω 92Ω 90ΩΔV 91.4 cc 99 cc 96.8 cc.Pulse rate 76 beats/min 75.5 beats/min 74 beats/minC.O 6.98 liters/min 7.48 liters/min 7.15 liters/min.______________________________________
Additional examples are given below in Table II, each example being taken from a different human subject using the braided copper-electrodes as described hereinabove and with a conductive material such as electrode paste to provide a low impedance electrical connection to the skin and to allow some movement between the skin and the electrodes. The electrodes were allowed to stand for a period of about five minutes in order that equilibrium is attained. Each human subject represented in Table II was a hospital patient having a heart defect. In some cases the tests were run after the defect had been repaired. A comparison is made in Table II between the cardiac output as determined by the system of the present invention and that obtained with the well known Fick pulmonary flow measurement on the same subject.
TABLE II______________________________________CARDIAC OUTPUT-FICK COMPARISON Percent Differ- ence between Fick pulmo-Fick nary flowEx. Systemic Pulmonary, Impedance and imped-No. flow,l./min. l./min. C.O.,l./min. ance C.O.______________________________________ 4 6.3 7.86 5.21 -31.3 5 2.5 4.8 5.5 +14.6 6 5.0 5.2 5.22 0 7 3.6 5.0 4.43 -11.4 8 3.1 5.9 6.29 +6.6 9 4.65 5.0 4.81 -3.810 4.0 4.0 4.13 +3.211 6.0 6.0 6.66 +11.012 4.7 4.7 4.24 -9.613 5.4 5.4 6.22 +15.214 5.9 5.9 6.2 +5.115 5.9 5.9 6.34 +7.416 6.1 6.1 6.62 +8.517 6.8 6.8 6.71 -1.318 -- 5.3 5.42 -6.519 2.7 2.7 2.9 +7.420 7.3 7.3 7.1 -2.721 5.65 5.65 6.19 +9.522 4.85 4.75 4.15 -12.623 -- 4.3 4.87 +13.224 7.7 7.7 8.08 +4.925 7.2 7.2 7.19 -1.426 4.0 4.9 5.09 +3.927 5.3 5.3 5.9 +11.3 1 ±8______________________________________ 1 Average difference.
For convenience, the invention has been described with reference to electrodes of particular configuration, number and location, excitation current of particular value, and the like. It will be readily understood, however, that wide variations are possible without materially altering the usefulness of the data obtained. For example, while band electrodes encircling the neck and lower thorax are described, the electrodes need not be in the form of bands, nor is it necessary that the body portions be encircled. The precise location and separation of the electrodes is not critical. The excitation electrodes must be positioned above and below the measuring electrodes. The upper excitation electrode is to be positioned at or above the upper border of the lungs and the lower excitation electrode is to be positioned at or below the lower border of the heart and lungs. Within these limits numerous variations are possible.
While the use of a 100 kc. excitation current has been described, it will be apparent that the plethysmograph system is not so limited. However, the desireability of using a standardized excitation current source so that the data obtained at different times and places, etc., can be compared and correlated will be readily appreciated.
It is apparent that many modifications and variations of this invention as hereinbefore set forth may be made without departing from the spirit and scope thereof. The specific embodiments described are given by way of example only and the invention is limited only by the terms of the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2184511 *||Oct 28, 1937||Dec 26, 1939||Abraham Barnett||Method and apparatus for measuring impedance|
|US3095872 *||Nov 27, 1959||Jul 2, 1963||Cutler Hammer Inc||Blood pressure measurement|
|US3144019 *||Aug 8, 1960||Aug 11, 1964||Edgar Haber||Cardiac monitoring device|
|US3149627 *||Apr 25, 1962||Sep 22, 1964||Bagno Samuel M||Plethysmograph|
|US3224435 *||Sep 10, 1962||Dec 21, 1965||Gulton Ind Inc||Method of measuring blood pressure|
|US3267933 *||Sep 10, 1962||Aug 23, 1966||Del Mar Eng Lab||Ekg computer|
|US3267934 *||Sep 20, 1962||Aug 23, 1966||Avionics Res Products Corp||Electrocardiac computer|
|US3280817 *||Jun 19, 1964||Oct 25, 1966||Bistable memory|
|1||*||Bishop; S. et al., Harper Hospital Bulletin, Jul.-Aug. 1962, pp. 142-143.|
|2||*||Nyboer; J., Electrical Impedance Plethysmography, 1954, Charles C. Thomas, Spfld. Ill., Publisher, pp. 50-57.|
|3||*||Zajic; F., et al., Physiologia Bohemoslovenica, vol. III, 1954, pp. 355-361.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4852580 *||Nov 6, 1987||Aug 1, 1989||Axiom Medical, Inc.||Catheter for measuring bioimpedance|
|US5063937 *||Sep 12, 1990||Nov 12, 1991||Wright State University||Multiple frequency bio-impedance measurement system|
|US5103828 *||Nov 28, 1990||Apr 14, 1992||Bomed Medical Manufacturing, Ltd.||System for therapeutic management of hemodynamic state of patient|
|US5203344 *||Jan 31, 1991||Apr 20, 1993||Brigham And Women's Hospital||Method and apparatus for taking bioelectrical impedance measurements using proximally positioned electrodes|
|US5309917 *||Feb 12, 1992||May 10, 1994||Drexel University||System and method of impedance cardiography and heartbeat determination|
|US5423326 *||May 14, 1993||Jun 13, 1995||Drexel University||Apparatus and method for measuring cardiac output|
|US5443073 *||May 13, 1993||Aug 22, 1995||Drexel University||System and method of impedance cardiography monitoring|
|US5732710 *||Aug 9, 1996||Mar 31, 1998||R.S. Medical Monitoring Ltd.||Method and device for stable impedance plethysmography|
|US5735284 *||Jun 13, 1995||Apr 7, 1998||N.I. Medical Ltd.||Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body|
|US5749369 *||Mar 17, 1997||May 12, 1998||R.S. Medical Monitoring Ltd.||Method and device for stable impedance plethysmography|
|US5782774 *||Oct 4, 1996||Jul 21, 1998||Imagyn Medical Technologies California, Inc.||Apparatus and method of bioelectrical impedance analysis of blood flow|
|US6561986||Jan 17, 2001||May 13, 2003||Cardiodynamics International Corporation||Method and apparatus for hemodynamic assessment including fiducial point detection|
|US6602201||Jul 10, 2001||Aug 5, 2003||Cardiodynamics International Corporation||Apparatus and method for determining cardiac output in a living subject|
|US6636754||Jul 10, 2000||Oct 21, 2003||Cardiodynamics International Corporation||Apparatus and method for determining cardiac output in a living subject|
|US6882879||Jul 18, 2001||Apr 19, 2005||Innovamedica S.A. De C.V.||Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs|
|US6907288||Jun 12, 2001||Jun 14, 2005||Cardiac Pacemakers, Inc.||Cardiac rhythm management system adjusting rate response factor for treating hypotension|
|US6912420||Apr 10, 2001||Jun 28, 2005||Cardiac Pacemakers, Inc.||Cardiac rhythm management system for hypotension|
|US7149576||Mar 19, 2003||Dec 12, 2006||Cardiodynamics International Corporation||Apparatus and method for defibrillation of a living subject|
|US7177681||Apr 11, 2003||Feb 13, 2007||Cardiac Pacemakers, Inc.||Cardiac rhythm management system for edema|
|US7191000||Jul 31, 2001||Mar 13, 2007||Cardiac Pacemakers, Inc.||Cardiac rhythm management system for edema|
|US7251524||Jul 8, 2003||Jul 31, 2007||Cardiodynamics International Corporation||Apparatus and method for determining cardiac output in a living subject|
|US7340296||May 18, 2005||Mar 4, 2008||Cardiac Pacemakers, Inc.||Detection of pleural effusion using transthoracic impedance|
|US7387610||Aug 19, 2004||Jun 17, 2008||Cardiac Pacemakers, Inc.||Thoracic impedance detection with blood resistivity compensation|
|US7474918 *||Mar 24, 2005||Jan 6, 2009||Noninvasive Medical Technologies, Inc.||Thoracic impedance monitor and electrode array and method of use|
|US7570989||Nov 22, 2004||Aug 4, 2009||Cardiodynamics International Corporation||Method and apparatus for signal assessment including event rejection|
|US7603170||Apr 26, 2005||Oct 13, 2009||Cardiac Pacemakers, Inc.||Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance|
|US7650183||Sep 19, 2005||Jan 19, 2010||Critical Perfusion, Inc.||Impedance spectroscopy system for ischemic mucosal damage monitoring in hollow viscous organs|
|US7668585||Dec 19, 2003||Feb 23, 2010||Koninklijke Philips Electronics N.V.||Respiration monitor for computed tomography|
|US7672718||Jun 16, 2008||Mar 2, 2010||Cardiac Pacemakers, Inc.||Thoracic impedance detection with blood resistivity compensation|
|US7783345 *||Apr 7, 2005||Aug 24, 2010||Cnsystems Medizintechnik Gmbh||Impedance-based measuring method for hemodynamic parameters|
|US7856261||Dec 5, 2005||Dec 21, 2010||Koninklijke Philips Electronics N.V.||Cable with spacer for positioning multiple medical sensors|
|US7881781||Dec 1, 2009||Feb 1, 2011||Cardiac Pacemakers, Inc.||Thoracic impedance detection with blood resistivity compensation|
|US7907997||May 11, 2005||Mar 15, 2011||Cardiac Pacemakers, Inc.||Enhancements to the detection of pulmonary edema when using transthoracic impedance|
|US7917209||Jun 27, 2005||Mar 29, 2011||Physio-Control, Inc.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US7979115||Jan 10, 2008||Jul 12, 2011||Cardiac Pacemakers, Inc.||Detection of pleural effusion using transthoracic impedance|
|US8068906||Jul 11, 2007||Nov 29, 2011||Aorora Technologies Pty Ltd||Cardiac monitoring system|
|US8092392||Apr 19, 2007||Jan 10, 2012||Physio-Control, Inc.||Pulse detection method and apparatus using patient impedance|
|US8116841||Sep 12, 2008||Feb 14, 2012||Corventis, Inc.||Adherent device with multiple physiological sensors|
|US8135462||Apr 17, 2008||Mar 13, 2012||Physio-Control, Inc.||Pulse detection using patient physiological signals|
|US8160703||Jul 22, 2005||Apr 17, 2012||Physio-Control, Inc.||Apparatus, software, and methods for cardiac pulse detection using a piezoelectric sensor|
|US8200326||Sep 10, 2009||Jun 12, 2012||Cardiac Pacemakers, Inc.||Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance|
|US8233974||Jan 29, 2004||Jul 31, 2012||Impedimed Limited||Method and device for measuring tissue oedema|
|US8239024||Feb 22, 2011||Aug 7, 2012||Physio-Control, Inc.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US8249686||Sep 12, 2008||Aug 21, 2012||Corventis, Inc.||Adherent device for sleep disordered breathing|
|US8285356||Jan 10, 2012||Oct 9, 2012||Corventis, Inc.||Adherent device with multiple physiological sensors|
|US8374688||Sep 12, 2008||Feb 12, 2013||Corventis, Inc.||System and methods for wireless body fluid monitoring|
|US8386041||Jun 21, 2006||Feb 26, 2013||St. Jude Medical Ab||Medical device and system for determining a hemodynamic parameter using intracardiac impedance|
|US8388545||Jan 18, 2006||Mar 5, 2013||Cheetah Medical, Inc.||System, method and apparatus for measuring blood flow and blood volume|
|US8412317||Apr 20, 2009||Apr 2, 2013||Corventis, Inc.||Method and apparatus to measure bioelectric impedance of patient tissue|
|US8414498 *||May 10, 2004||Apr 9, 2013||Cheetah Medical, Inc.||System, method and apparatus for measuring blood flow and blood volume|
|US8460189||Sep 12, 2008||Jun 11, 2013||Corventis, Inc.||Adherent cardiac monitor with advanced sensing capabilities|
|US8483818||Feb 23, 2011||Jul 9, 2013||Cardiac Pacemakers, Inc.||Enhancements to the detection of pulmonary edema when using transthoracic impedance|
|US8509886||Nov 28, 2011||Aug 13, 2013||Aorora Technologies Pty Ltd||Cardiac monitoring system|
|US8523777||Apr 15, 2008||Sep 3, 2013||Cheetah Medical, Inc.||Method, apparatus and system for predicting electromechanical dissociation|
|US8532766||Oct 6, 2011||Sep 10, 2013||Physio-Control, Inc.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US8591425||Oct 21, 2011||Nov 26, 2013||Physio-Control, Inc.||Pulse detection using patient physiological signals|
|US8591430||Sep 12, 2008||Nov 26, 2013||Corventis, Inc.||Adherent device for respiratory monitoring|
|US8610022 *||Dec 27, 2011||Dec 17, 2013||Emilio Sacristan Rock||Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs|
|US8663121||Jan 15, 2010||Mar 4, 2014||Physio-Control, Inc.||Pulse detection method and apparatus using patient impedance|
|US8684925||Sep 12, 2008||Apr 1, 2014||Corventis, Inc.||Injectable device for physiological monitoring|
|US8700121||Dec 14, 2012||Apr 15, 2014||Intersection Medical, Inc.||Devices for determining the relative spatial change in subsurface resistivities across frequencies in tissue|
|US8718752||Mar 11, 2009||May 6, 2014||Corventis, Inc.||Heart failure decompensation prediction based on cardiac rhythm|
|US8744577||Aug 7, 2012||Jun 3, 2014||Physio-Control, Inc.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US8761870||May 25, 2007||Jun 24, 2014||Impedimed Limited||Impedance measurements|
|US8764667||Mar 6, 2008||Jul 1, 2014||Cheetah Medical, Inc.||Method and system for monitoring sleep|
|US8781551||Jun 30, 2006||Jul 15, 2014||Impedimed Limited||Apparatus for connecting impedance measurement apparatus to an electrode|
|US8790257||Sep 12, 2008||Jul 29, 2014||Corventis, Inc.||Multi-sensor patient monitor to detect impending cardiac decompensation|
|US8790259||Oct 22, 2010||Jul 29, 2014||Corventis, Inc.||Method and apparatus for remote detection and monitoring of functional chronotropic incompetence|
|US8790267||Aug 11, 2008||Jul 29, 2014||Cheetah Medical, Inc.||Dynamically variable filter|
|US8876725||Feb 21, 2008||Nov 4, 2014||Cheetah Medical, Inc.||Method and system for estimating exercise capacity|
|US8897868||Sep 12, 2008||Nov 25, 2014||Medtronic, Inc.||Medical device automatic start-up upon contact to patient tissue|
|US8965498||Mar 28, 2011||Feb 24, 2015||Corventis, Inc.||Method and apparatus for personalized physiologic parameters|
|US8992432||Oct 21, 2011||Mar 31, 2015||Physio-Control, Inc.||Pulse detection using patient physiological signals|
|US9089275||May 11, 2005||Jul 28, 2015||Cardiac Pacemakers, Inc.||Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance|
|US9095271||Aug 13, 2007||Aug 4, 2015||Cheetah Medical, Inc.||Dynamically variable filter|
|US9149225||Dec 14, 2012||Oct 6, 2015||Intesection Medical, Inc.||Methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue|
|US9173615||Sep 23, 2014||Nov 3, 2015||Medtronic Monitoring, Inc.||Method and apparatus for personalized physiologic parameters|
|US9186089||Sep 12, 2008||Nov 17, 2015||Medtronic Monitoring, Inc.||Injectable physiological monitoring system|
|US20020147475 *||Apr 10, 2001||Oct 10, 2002||Avram Scheiner||Cardiac rhythm management system for hypotension|
|US20020147476 *||Jun 12, 2001||Oct 10, 2002||Daum Douglas R.||Cardiac rhythm management system adjusting rate response factor for treating hypotension|
|US20030028221 *||Jul 31, 2001||Feb 6, 2003||Qingsheng Zhu||Cardiac rhythm management system for edema|
|US20030060723 *||Aug 26, 2002||Mar 27, 2003||Medtronic Physio-Control Manufacturing Corp.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US20040039420 *||Aug 26, 2002||Feb 26, 2004||Medtronic Physio-Control Manufacturing Corp.||Apparatus, software, and methods for cardiac pulse detection using accelerometer data|
|US20040116969 *||Sep 2, 2003||Jun 17, 2004||Owen James M.||Pulse detection using patient physiological signals|
|US20040186392 *||Jan 29, 2004||Sep 23, 2004||The University Of Queensland||Method and device for measuring tissue oedema|
|US20040243192 *||Jun 2, 2003||Dec 2, 2004||Hepp Dennis G.||Physiologic stimulator tuning apparatus and method|
|US20050177062 *||Apr 7, 2005||Aug 11, 2005||Cnsystems Medizintechnik Gmbh||Impedance-based measuring method for hemodynamic parameters|
|US20050203427 *||Mar 15, 2004||Sep 15, 2005||Impedance Vascular Imaging Products, Llc||Stenosis detection device|
|US20050203428 *||Mar 15, 2004||Sep 15, 2005||Impedance Vascular Imaging Products, Llc||Device and method for determining coronary blood flow|
|US20050203429 *||Mar 15, 2004||Sep 15, 2005||Impedance Vascular Imaging Products, Llc||Device and method for measuring cardiac function|
|US20050215918 *||Mar 24, 2005||Sep 29, 2005||Frantz Ann K||Thoracic impedance monitor and electrode array and method of use|
|US20050240234 *||Jun 27, 2005||Oct 27, 2005||Medtronic Emergency Response Systems, Inc.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US20060015035 *||Sep 19, 2005||Jan 19, 2006||Rock Emilio S||Impedance spectroscopy system for ischemic mucosal damage monitoring in hollow viscous organs|
|US20060074300 *||Dec 19, 2003||Apr 6, 2006||Koninklijke Philips Electronics N.V.||Respiration monitor for computed tomography|
|US20060111642 *||Nov 22, 2004||May 25, 2006||Baura Gail D||Method and apparatus for signal assessment including event rejection|
|US20060200033 *||May 10, 2004||Sep 7, 2006||Cheetah Medical Inc. C/O Pepper Hamiton||System, method and apparatus for measuring blood flow and blood volume|
|US20060241513 *||Apr 26, 2005||Oct 26, 2006||Cardiac Pacemakers, Inc.||Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance|
|US20060247543 *||Oct 9, 2003||Nov 2, 2006||Bruce Cornish||High resoution bio-impedance device|
|US20070288060 *||Apr 19, 2007||Dec 13, 2007||Stickney Ronald E||Pulse Detection Method and Apparatus Using Patient Impedance|
|US20080287823 *||Jul 19, 2006||Nov 20, 2008||Scott Matthew Chetham||Index Determination|
|US20090043222 *||Oct 10, 2006||Feb 12, 2009||Scott Chetham||Hydration status monitoring|
|US20090048497 *||Aug 13, 2007||Feb 19, 2009||Cheetah Medical Ltd.||Dynamically variable filter|
|US20090143663 *||Jun 30, 2006||Jun 4, 2009||Impedance Cardiology Systems Inc.||Pulmonary Monitoring System|
|US20120179018 *||Dec 27, 2011||Jul 12, 2012||Emilio Sacristan Rock||Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs|
|USRE44667||Apr 12, 2007||Dec 24, 2013||Critical Perfusion, Inc.|
|CN100502780C||Dec 19, 2003||Jun 24, 2009||皇家飞利浦电子股份有限公司||Respiration monitor for computed tomography|
|EP1275342A2||Jul 10, 2002||Jan 15, 2003||CardioDynamics International Corporation||Apparatus and method for determining cardiac output in a living subject|
|WO1989003656A1 *||Oct 17, 1988||May 5, 1989||Bomed Medical Mfg||Noninvasive continuous mean arterial blood pressure monitor|
|WO1990000367A1 *||Jul 11, 1989||Jan 25, 1990||Bomed Medical Mfg||Management of hemodynamic state of a patient|
|WO1993004627A1 *||Sep 11, 1992||Mar 18, 1993||Univ Drexel||Methods of impedance cardiography and heartbeat determination|
|WO1997009928A1 *||Sep 6, 1996||Mar 20, 1997||Foerster Harald||Process and device for determining the cardiac output|
|WO1997038628A1 *||Apr 17, 1997||Oct 23, 1997||Ascher Shmulewitz||Apparatus and methods of bioelectrical impedance analysis of blood flow|
|WO1998006328A1||Jul 28, 1997||Feb 19, 1998||Friedman Mark M||Method and device for stable impedance plethysmography|
|WO2001041638A1 *||Dec 4, 2000||Jun 14, 2001||Imagyn Medical Technologies Ca||Apparatus and methods of bioelectrical impedance analysis of blood flow|
|WO2001062147A1||Feb 14, 2001||Aug 30, 2001||Heska Corp||Apparatus for evaluating cardiac functions via esophagus|
|WO2002078539A1||Mar 21, 2002||Oct 10, 2002||Daniel Goor||Device for determining hemodynamic state|
|WO2004062501A2 *||Dec 19, 2003||Jul 29, 2004||James W Green||Respiration monitor for computed tomography|
|WO2007149018A1 *||Jun 21, 2006||Dec 27, 2007||St Jude Medical||Medical device and system for determining a hemodynamic parameter using intracardiac impedance|
|U.S. Classification||600/526, 600/547|
|International Classification||A61B5/026, A61B5/053|
|Cooperative Classification||A61B5/026, A61B5/0535|
|European Classification||A61B5/026, A61B5/053F|